The largest-ever prospective study in the detection of malignant melanoma shows convincing results for Nevisense.
“The number one advantage regarding Nevisense is that it backs up my decision and provides me with more certainty in whether or not to excise a lesion.”
Dr. Isabel Gahlen, Germany
Fall Clinical Dermatology Conference
Las Vegas, USA
October 12-15, 2017